Palomino Laboratories Inc.
Palomino Laboratories Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | - | - | - | - | 0 | 0 | - | 0 | 0 | 0 | 0 | - | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 19 | 7 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | |||||
Assets Current | 20 | 7 | 8 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | 1 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Operating Lease Right Of Use Asset | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Deferred Costs | - | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Other Assets | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Assets | 21 | 7 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable And Accrued Liabilities Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Notes Payable Current | - | - | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Convertible Notes Payable Current | - | - | - | - | 0 | - | - | - | - | - | - | - | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | |||||
Accrued Liabilities And Other Liabilities | 0 | 0 | 0 | 1 | - | - | - | - | - | - | - | - | |||||
Other Liabilities Current | - | - | - | 0 | - | - | 0 | - | - | - | - | - | |||||
Operating Lease Liability Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Liabilities Current | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Noncurrent | - | - | - | - | - | - | 0 | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Liabilities | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 26 | 11 | 11 | 10 | - | - | -0 | - | - | - | - | - | |||||
Retained Earnings Accumulated Deficit | -6 | -4 | -3 | -2 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Stockholders Equity | 21 | 7 | 8 | 7 | -0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Liabilities And Stockholders Equity | 21 | 7 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 50 | 50 | 300 | 50 | 50 | 50 | 50 | 50 | |||||
Common Stock Shares Issued | 23 | 19 | 19 | 18 | 2 | 2 | 5 | 2 | 2 | 2 | 2 | 2 | |||||
Shares Outstanding | 23 | 19 | 19 | 18 | 2 | 2 | 5 | 2 | 2 | 2 | 2 | 2 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q2 1 Month | Q2 2 Month | Q2 3 Month |
|---|---|---|---|
| 2026 | - | - | - |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | |||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Palomino Laboratories Inc. (PALX) — SEC Financial Statements & Analysis
Palomino Laboratories Inc. (PALX) is a semiconductors & related devices company, incorporated in DE. Palomino Laboratories Inc. trades on OTC as: PALX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Palomino Laboratories Inc. reported a Debt-to-Equity ratio of 0.02x. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.02x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Palomino Laboratories Inc. in?
Palomino Laboratories Inc. (PALX) operates in the Semiconductors & Related Devices industry.
What exchange does PALX trade on?
Palomino Laboratories Inc. (PALX) trades on the OTC.
Where is Palomino Laboratories Inc. incorporated?
Palomino Laboratories Inc. is incorporated in DE.